(Q38185071)

30 August 2017

title

Endocannabinoids and neuropathic pain: focus on neuron-glia and endocannabinoid-neurotrophin interactions (English)

1 reference

30 August 2017

0 references

0 references

1 reference

1

1 reference

30 August 2017

3

1 reference

30 August 2017

Sabatino Maione

2

1 reference

30 August 2017

language of work or name

English

0 references

publication date

1 February 2014

1 reference

European Journal of Neuroscience

30 August 2017

published in

1 reference

30 August 2017

volume

39

1 reference

30 August 2017

issue

3

1 reference

30 August 2017

page(s)

401-408

1 reference

The CB1 cannabinoid receptor mediates excitotoxicity-induced neural progenitor proliferation and neurogenesis

30 August 2017

cites work

1 reference

The effect of neurotrophic factors on morphology, TRPV1 expression and capsaicin responses of cultured human DRG sensory neurons

21 January 2018

1 reference

Targeting CB2 receptors and the endocannabinoid system for the treatment of pain

21 January 2018

1 reference

Early endogenous activation of CB1 and CB2 receptors after spinal cord injury is a protective response involved in spontaneous recovery.

21 January 2018

1 reference

BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1 knockout mice

21 January 2018

1 reference

T-type calcium channel inhibition underlies the analgesic effects of the endogenous lipoamino acids.

21 January 2018

1 reference

Corticotropin-releasing hormone-mediated induction of intracellular signaling pathways and brain-derived neurotrophic factor expression is inhibited by the activation of the endocannabinoid system

21 January 2018

1 reference

CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms.

21 January 2018

1 reference

Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptor

21 January 2018

1 reference

Cannabinoid receptors and endocannabinoids: role in neuroinflammatory and neurodegenerative disorders

21 January 2018

1 reference

Control of pain initiation by endogenous cannabinoids.

21 January 2018

1 reference

Endocannabinoids inhibit release of nerve growth factor by inflammation-activated mast cells

21 January 2018

1 reference

Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism

21 January 2018

1 reference

Cathepsin S release from primary cultured microglia is regulated by the P2X7 receptor

21 January 2018

1 reference

CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain

21 January 2018

1 reference

Effect of the cannabinoid CB1 receptor antagonist, SR141716, on nociceptive response and nerve demyelination in rodents with chronic constriction injury of the sciatic nerve

21 January 2018

1 reference

The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB(1), TRPV1 and PPARgamma receptors and neurotrophic factors

21 January 2018

1 reference

BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain

21 January 2018

1 reference

The endogenous cannabinoid system and its role in nociceptive behavior

21 January 2018

1 reference

Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum.

21 January 2018

1 reference

Regulation of transient receptor potential channels of melastatin type 8 (TRPM8): effect of cAMP, cannabinoid CB(1) receptors and endovanilloids

21 January 2018

1 reference

'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance.

21 January 2018

1 reference

Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells

21 January 2018

1 reference

A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation

21 January 2018

1 reference

Antidepressant-like effects of Δ⁹-tetrahydrocannabinol and rimonabant in the olfactory bulbectomised rat model of depression

21 January 2018

1 reference

Chronic exposure of sensory neurones to increased levels of nerve growth factor modulates CB1/TRPV1 receptor crosstalk

21 January 2018

1 reference

A novel neuroimmune mechanism in cannabinoid-mediated attenuation of nerve growth factor-induced hyperalgesia

21 January 2018

1 reference

Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB(1) and CB(2)-like receptors

21 January 2018

1 reference

Fatty acid amide hydrolase: biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonoylglycerol, palmitoylethanolamide, and oleamide

21 January 2018

1 reference

Discovery of prostamide F2α and its role in inflammatory pain and dorsal horn nociceptive neuron hyperexcitability

21 January 2018

1 reference

TRPV1-dependent and -independent alterations in the limbic cortex of neuropathic mice: impact on glial caspases and pain perception

21 January 2018

1 reference

Cannabinoids and Neuropathic Pain

21 January 2018

1 reference

Minocycline treatment inhibits microglial activation and alters spinal levels of endocannabinoids in a rat model of neuropathic pain.

21 January 2018

1 reference

The cannabinergic system is implicated in the upregulation of central NGF protein by psychotropic drugs.

21 January 2018

1 reference

Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation

21 January 2018

1 reference

Intense exercise increases circulating endocannabinoid and BDNF levels in humans--possible implications for reward and depression.

21 January 2018

1 reference

DAGLβ inhibition perturbs a lipid network involved in macrophage inflammatory responses

21 January 2018

1 reference

Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS

21 January 2018

1 reference

CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids

21 January 2018

1 reference

Activation of spinal cannabinoid CB2 receptors inhibits neuropathic pain in streptozotocin-induced diabetic mice

21 January 2018

1 reference

Cannabinoid CB2 receptor-mediated anti-nociception in models of acute and chronic pain

21 January 2018

1 reference

The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects

21 January 2018

1 reference

Adverse effects of cannabis on health: an update of the literature since 1996.

21 January 2018

1 reference

Nerve growth factor scales endocannabinoid signaling by regulating monoacylglycerol lipase turnover in developing cholinergic neurons

21 January 2018

1 reference

Fatty acid amide hydrolase and monoacylglycerol lipase inhibitors produce anti-allodynic effects in mice through distinct cannabinoid receptor mechanisms.

21 January 2018

1 reference

Lack of analgesia by oral standardized cannabis extract on acute inflammatory pain and hyperalgesia in volunteers.

21 January 2018

1 reference

2-Arachidonoylglycerol elicits neuroprotective effects on excitotoxically lesioned dentate gyrus granule cells via abnormal-cannabidiol-sensitive receptors on microglial cells.

21 January 2018

1 reference

Spinal cannabinoid receptor type 2 agonist reduces mechanical allodynia and induces mitogen-activated protein kinase phosphatases in a rat model of neuropathic pain

21 January 2018

1 reference

GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current

21 January 2018

1 reference

BDNF evokes release of endogenous cannabinoids at layer 2/3 inhibitory synapses in the neocortex

21 January 2018

1 reference

Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid typ

21 January 2018

1 reference

Endocannabinoids: a unique opportunity to develop multitarget analgesics

21 January 2018

1 reference

BDNF regulates neuronal sensitivity to endocannabinoids

21 January 2018

1 reference

Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli.

21 January 2018

1 reference

The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors

21 January 2018

1 reference

Involvement of the cAMP/protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells

21 January 2018

1 reference

Cannabinoid CB(2) receptor attenuates morphine-induced inflammatory responses in activated microglial cells

21 January 2018

1 reference

The induction of pain: an integrative review

21 January 2018

1 reference

Molecular characterization of a peripheral receptor for cannabinoids

21 January 2018

1 reference

The blockade of the transient receptor potential vanilloid type 1 and fatty acid amide hydrolase decreases symptoms and central sequelae in the medial prefrontal cortex of neuropathic rats

21 January 2018

1 reference

Receptor-independent actions of cannabinoids on cell membranes: focus on endocannabinoids

21 January 2018

1 reference

Neuropathic pain and the endocannabinoid system in the dorsal raphe: pharmacological treatment and interactions with the serotonergic system

21 January 2018

1 reference

An endogenous cannabinoid (2-AG) is neuroprotective after brain injury

21 January 2018

1 reference

Spinal endocannabinoids and CB1 receptors mediate C-fiber-induced heterosynaptic pain sensitization.

21 January 2018

1 reference

Cannabinoid receptors and pain

21 January 2018

1 reference

Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats

21 January 2018

1 reference

Crucial role of CB(2) cannabinoid receptor in the regulation of central immune responses during neuropathic pain

21 January 2018

1 reference

Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy

21 January 2018

1 reference

Spinal microglial and perivascular cell cannabinoid receptor type 2 activation reduces behavioral hypersensitivity without tolerance after peripheral nerve injury

21 January 2018

1 reference

The major central endocannabinoid directly acts at GABA(A) receptors

21 January 2018

1 reference

Non-psychotropic analgesic drugs from the endocannabinoid system: "magic bullet" or "multiple-target" strategies?

21 January 2018

1 reference

Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice.

21 January 2018

1 reference

Selective inhibition of alpha/beta-hydrolase domain 6 attenuates neurodegeneration, alleviates blood brain barrier breakdown, and improves functional recovery in a mouse model of traumatic brain injury

21 January 2018

1 reference

N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA).

21 January 2018

1 reference

Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy

21 January 2018

1 reference

Identification and functional characterization of brainstem cannabinoid CB2 receptors

21 January 2018

1 reference

Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models

21 January 2018

1 reference

The effect of the palmitoylethanolamide analogue, palmitoylallylamide (L-29) on pain behaviour in rodent models of neuropathy

21 January 2018

1 reference

Astrocytes in culture produce anandamide and other acylethanolamides.

21 January 2018

1 reference

Spinal cord glia: new players in pain

21 January 2018

1 reference

P2X7 receptors control 2-arachidonoylglycerol production by microglial cells

21 January 2018

1 reference

Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection

21 January 2018

1 reference

Molecular sites for the positive allosteric modulation of glycine receptors by endocannabinoids

21 January 2018

1 reference

Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models

21 January 2018

1 reference

Cannabinoid CB(1) receptor activation stimulates neurite outgrowth and inhibits capsaicin-induced Ca(2+) influx in an in vitro model of diabetic neuropathy.

21 January 2018

1 reference

Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide

21 January 2018

1 reference

1-(2′,4′-dichlorophenyl)-6-methyl-N-cyclohexylamine-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamide, a novel CB2 agonist, alleviates neuropathic pain through functional microglial changes in mice

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/EJN.12440

1 reference

30 August 2017

1 reference